Combination reperfusion therapy with eptifibatide and reduced-dose tenecteplase for ST-elevation myocardial infarction
- 15 April 2003
- journal article
- clinical trial
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 41 (8), 1251-1260
- https://doi.org/10.1016/s0735-1097(03)00123-2
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Enoxaparin as Adjunctive Antithrombin Therapy for ST-Elevation Myocardial InfarctionCirculation, 2002
- Eptifibatide and low-dose tissue plasminogen activator in acute myocardial infarction: The integrilin and low-dose thrombolysis in acute myocardial infarction (INTRO AMI) trialJournal of the American College of Cardiology, 2002
- Incidence and predictors of bleeding events after fibrinolytic therapy with fibrin-specific agents. A comparison of TNK-tPA and rt-PAPublished by Oxford University Press (OUP) ,2001
- Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trialThe Lancet, 2001
- Combination reperfusion therapy with abciximab and reduced dose reteplase: results from TIMI 14Published by Oxford University Press (OUP) ,2000
- Safety and efficacy of eptifibatide vs placebo in patients receiving thrombolytic therapy with streptokinase for acute myocardial infarction. A phase II dose escalation, randomized, double-blind studyPublished by Oxford University Press (OUP) ,2000
- St-segment resolution and infarct-related artery patency and flow after thrombolytic therapyThe American Journal of Cardiology, 2000
- Overcoming thrombolytic resistance: Rationale and initial clinical experience combining thrombolytic therapy and glycoprotein IIb/IIIa receptor inhibition for acute myocardial infarctionJournal of the American College of Cardiology, 1999
- 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarctionJournal of the American College of Cardiology, 1999
- The Effects of Tissue Plasminogen Activator, Streptokinase, or Both on Coronary-Artery Patency, Ventricular Function, and Survival after Acute Myocardial InfarctionNew England Journal of Medicine, 1993